Langerhans cell histiocytosis - a 31 year review

P. Leavey, M. Varughese, F. Breatnach, A. O'Meara

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Forty-one patients with Langerhans Cell Histiocytosis (LCH) were treated over a thirty-one year period in our institution. These children were classified according to the number of systems involved: twenty-two had unisystem disease while nineteen had multisystem disease. A histological diagnosis was reached in 82 % of cases, the remainder being diagnosed on both radiological and clinical grounds. 68 % of those with multisystem disease had a rash at diagnosis whilst 64% had a persistent ear discharge. The diagnosis was established accidentally in 25% of those with unisystem disease. The mortality rate was 21 % and was confined to those who were under two years of age at diagnosis, all of whom had multisystem disease. Morbidity was 20% and was restricted to patients with multisystem disease. Only one patient died within the last 10 years; there were no therapy related deaths. Treatment related morbidity was seen in only three children. In keeping with other series, our review has identified the following adverse prognostic factors a) age under 2 years at presentation, b) multisystem disease and c) major organ dysfunction. In view of the natural history of the disease, it is suggested that chemotherapy only be used in those patients who have major organ dysfunction or progressive disease and that radiotherapy is rarely indicated.

Original languageEnglish (US)
Pages (from-to)271-274
Number of pages4
JournalIrish Journal of Medical Science
Volume160
Issue number9
DOIs
StatePublished - Jan 1991

Fingerprint

Langerhans Cell Histiocytosis
Morbidity
Exanthema
Ear
Radiotherapy
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Langerhans cell histiocytosis - a 31 year review. / Leavey, P.; Varughese, M.; Breatnach, F.; O'Meara, A.

In: Irish Journal of Medical Science, Vol. 160, No. 9, 01.1991, p. 271-274.

Research output: Contribution to journalArticle

Leavey, P, Varughese, M, Breatnach, F & O'Meara, A 1991, 'Langerhans cell histiocytosis - a 31 year review', Irish Journal of Medical Science, vol. 160, no. 9, pp. 271-274. https://doi.org/10.1007/BF02948410
Leavey, P. ; Varughese, M. ; Breatnach, F. ; O'Meara, A. / Langerhans cell histiocytosis - a 31 year review. In: Irish Journal of Medical Science. 1991 ; Vol. 160, No. 9. pp. 271-274.
@article{0123724e44fa49f7954ef16de9990a85,
title = "Langerhans cell histiocytosis - a 31 year review",
abstract = "Forty-one patients with Langerhans Cell Histiocytosis (LCH) were treated over a thirty-one year period in our institution. These children were classified according to the number of systems involved: twenty-two had unisystem disease while nineteen had multisystem disease. A histological diagnosis was reached in 82 {\%} of cases, the remainder being diagnosed on both radiological and clinical grounds. 68 {\%} of those with multisystem disease had a rash at diagnosis whilst 64{\%} had a persistent ear discharge. The diagnosis was established accidentally in 25{\%} of those with unisystem disease. The mortality rate was 21 {\%} and was confined to those who were under two years of age at diagnosis, all of whom had multisystem disease. Morbidity was 20{\%} and was restricted to patients with multisystem disease. Only one patient died within the last 10 years; there were no therapy related deaths. Treatment related morbidity was seen in only three children. In keeping with other series, our review has identified the following adverse prognostic factors a) age under 2 years at presentation, b) multisystem disease and c) major organ dysfunction. In view of the natural history of the disease, it is suggested that chemotherapy only be used in those patients who have major organ dysfunction or progressive disease and that radiotherapy is rarely indicated.",
author = "P. Leavey and M. Varughese and F. Breatnach and A. O'Meara",
year = "1991",
month = "1",
doi = "10.1007/BF02948410",
language = "English (US)",
volume = "160",
pages = "271--274",
journal = "The Dublin Journal of Medical and Chemical Science",
issn = "0332-1029",
publisher = "Springer London",
number = "9",

}

TY - JOUR

T1 - Langerhans cell histiocytosis - a 31 year review

AU - Leavey, P.

AU - Varughese, M.

AU - Breatnach, F.

AU - O'Meara, A.

PY - 1991/1

Y1 - 1991/1

N2 - Forty-one patients with Langerhans Cell Histiocytosis (LCH) were treated over a thirty-one year period in our institution. These children were classified according to the number of systems involved: twenty-two had unisystem disease while nineteen had multisystem disease. A histological diagnosis was reached in 82 % of cases, the remainder being diagnosed on both radiological and clinical grounds. 68 % of those with multisystem disease had a rash at diagnosis whilst 64% had a persistent ear discharge. The diagnosis was established accidentally in 25% of those with unisystem disease. The mortality rate was 21 % and was confined to those who were under two years of age at diagnosis, all of whom had multisystem disease. Morbidity was 20% and was restricted to patients with multisystem disease. Only one patient died within the last 10 years; there were no therapy related deaths. Treatment related morbidity was seen in only three children. In keeping with other series, our review has identified the following adverse prognostic factors a) age under 2 years at presentation, b) multisystem disease and c) major organ dysfunction. In view of the natural history of the disease, it is suggested that chemotherapy only be used in those patients who have major organ dysfunction or progressive disease and that radiotherapy is rarely indicated.

AB - Forty-one patients with Langerhans Cell Histiocytosis (LCH) were treated over a thirty-one year period in our institution. These children were classified according to the number of systems involved: twenty-two had unisystem disease while nineteen had multisystem disease. A histological diagnosis was reached in 82 % of cases, the remainder being diagnosed on both radiological and clinical grounds. 68 % of those with multisystem disease had a rash at diagnosis whilst 64% had a persistent ear discharge. The diagnosis was established accidentally in 25% of those with unisystem disease. The mortality rate was 21 % and was confined to those who were under two years of age at diagnosis, all of whom had multisystem disease. Morbidity was 20% and was restricted to patients with multisystem disease. Only one patient died within the last 10 years; there were no therapy related deaths. Treatment related morbidity was seen in only three children. In keeping with other series, our review has identified the following adverse prognostic factors a) age under 2 years at presentation, b) multisystem disease and c) major organ dysfunction. In view of the natural history of the disease, it is suggested that chemotherapy only be used in those patients who have major organ dysfunction or progressive disease and that radiotherapy is rarely indicated.

UR - http://www.scopus.com/inward/record.url?scp=0026318153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026318153&partnerID=8YFLogxK

U2 - 10.1007/BF02948410

DO - 10.1007/BF02948410

M3 - Article

C2 - 1769807

AN - SCOPUS:0026318153

VL - 160

SP - 271

EP - 274

JO - The Dublin Journal of Medical and Chemical Science

JF - The Dublin Journal of Medical and Chemical Science

SN - 0332-1029

IS - 9

ER -